RxDoctor Payments Data

Phinit Phisitkul, MD

Foot and Ankle Surgery · Sioux City, IANPI 1205090297

Payments from drug & device makers

What this record shows

This record is dominated by other: $839,211 of the $1,355,150 with a category attached, or 61.9%. Johnson & Johnson accounts for 61.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $910,969 and has fallen 90.0% since, to $91,192 in 2025. Among foot and ankle surgery clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,355,150in general payments, 2019–2025

Across 142 payments — averaging $9543.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$839K
  • Arthrex$474K
  • Smith+Nephew$32K
  • Crossroads Extremity Systems, LLC$4K
  • GLW, Inc$3K
  • Novastep Inc.$1K
  • plus $2K from 9 others
$43,500in ownership & investment interests, 2019–2025

Across 4 payments — averaging $10,875 each. An ownership or investment interest held by the physician or an immediate family member.

  • GLW, Inc$44K
  • Crossroads Extremity Systems, LLC$0

What the payments were for

  • Royalty or licence$458,63234%
  • Consulting fees$29,2162%
  • Speaking & faculty fees$14,5341%
  • Travel & lodging$9,2511%
  • Food & beverage$2,9500%
  • Education$1,3570%
  • Other$839,21162%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,355,150 in reported general payments places this provider in the 95th percentile of 112 foot and ankle surgery providers in Iowa.

See all foot and ankle surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$178,801
Medicare patients
299
Services billed
2,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$842
Gabapentin95$743
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen79$695
Ondansetron OdtOndansetron119$688
Hydroxyzine Pamoate84$310
Amitriptyline Hcl38$261
Cephalexin23$208
Tramadol Hcl12$23

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →